FDA taking closer look at ER drugs; Capsugel buys ionic liquids IP; FDA's Yu says agency wants quality top of mind;

> The FDA's Lawrence Yu, acting director of CDER's Office of Pharmaceutical Science, says the agency is making progress on quality manufacturing. Report

> India's Immunologicals, part of the National Dairy Development Board, will build a new veterinary vaccine manufacturing facility in Pondicherry. Story

> Capsugel has acquired the intellectual property for the ionic liquids technology developed at the Monash Institute of Pharmaceutical Sciences, Monash University. Release

> Healthcare packaging maker Platinum Press has bought a 60,000-sq.-ft. packaging facility in Pine Brook, NJ. Report

> The FDA says it will begin taking a closer look at how well extended-release drugs work, including how they are manufactured. Story

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.